One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
OBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
2001-12-01
|
Series: | Arquivos Brasileiros de Cardiologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2001001200006 |
id |
doaj-aa21d15acf1041c99c3d1244a84ddff6 |
---|---|
record_format |
Article |
spelling |
doaj-aa21d15acf1041c99c3d1244a84ddff62020-11-25T01:00:54ZengSociedade Brasileira de Cardiologia (SBC)Arquivos Brasileiros de Cardiologia0066-782X1678-41702001-12-0177655656110.1590/S0066-782X2001001200006One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trialLuiz Alberto MattosCindy L. GrinesJ. Eduardo de SousaAmanda G. M. R. SousaGregg W. StoneDavid CoxEulogio GarciaMarie-Claude MoriceWilliam O'NeillLorelei GrinesJudith BouraOBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting or primary coronary balloon angioplasty. METHODS - From the STENT PAMI trial, we analyzed the 6-month angiographic and 1-year clinical outcomes of 135 diabetic (112, noninsulin dependent) patients who underwent the randomization process of the trial and compared them with 758 nondiabetic patients. RESULTS - Coronary stenting did not significantly reduce the primary composite clinical end point when compared with PTCA (20 vs. 30%, p=0.2). A significant benefit from stenting was observed in patients with noninsulin dependent diabetes, with a trend toward a lesser need for new revascularization procedures (10 vs. 21%, p<.001), with a significant reduction in the primary composite clinical end point at 1 year (12 vs. 28%, p=. 04). At 6 months, the restenosis rate were significantly reduced only in nondiabetic patients (18 vs. 33%, p<. 001). Diabetic patients had the same restenosis rate (38%) either with stenting or balloon PTCA. CONCLUSIONS - Coronary Stenting in diabetics noninsulin dependent offered a significant reduction in the composite incidence of major clinical adverse events compared with balloon PTCA.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2001001200006myocardial infarctionstentsdiabetes mellitus |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luiz Alberto Mattos Cindy L. Grines J. Eduardo de Sousa Amanda G. M. R. Sousa Gregg W. Stone David Cox Eulogio Garcia Marie-Claude Morice William O'Neill Lorelei Grines Judith Boura |
spellingShingle |
Luiz Alberto Mattos Cindy L. Grines J. Eduardo de Sousa Amanda G. M. R. Sousa Gregg W. Stone David Cox Eulogio Garcia Marie-Claude Morice William O'Neill Lorelei Grines Judith Boura One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial Arquivos Brasileiros de Cardiologia myocardial infarction stents diabetes mellitus |
author_facet |
Luiz Alberto Mattos Cindy L. Grines J. Eduardo de Sousa Amanda G. M. R. Sousa Gregg W. Stone David Cox Eulogio Garcia Marie-Claude Morice William O'Neill Lorelei Grines Judith Boura |
author_sort |
Luiz Alberto Mattos |
title |
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial |
title_short |
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial |
title_full |
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial |
title_fullStr |
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial |
title_full_unstemmed |
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial |
title_sort |
one-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the stent pami trial |
publisher |
Sociedade Brasileira de Cardiologia (SBC) |
series |
Arquivos Brasileiros de Cardiologia |
issn |
0066-782X 1678-4170 |
publishDate |
2001-12-01 |
description |
OBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting or primary coronary balloon angioplasty. METHODS - From the STENT PAMI trial, we analyzed the 6-month angiographic and 1-year clinical outcomes of 135 diabetic (112, noninsulin dependent) patients who underwent the randomization process of the trial and compared them with 758 nondiabetic patients. RESULTS - Coronary stenting did not significantly reduce the primary composite clinical end point when compared with PTCA (20 vs. 30%, p=0.2). A significant benefit from stenting was observed in patients with noninsulin dependent diabetes, with a trend toward a lesser need for new revascularization procedures (10 vs. 21%, p<.001), with a significant reduction in the primary composite clinical end point at 1 year (12 vs. 28%, p=. 04). At 6 months, the restenosis rate were significantly reduced only in nondiabetic patients (18 vs. 33%, p<. 001). Diabetic patients had the same restenosis rate (38%) either with stenting or balloon PTCA. CONCLUSIONS - Coronary Stenting in diabetics noninsulin dependent offered a significant reduction in the composite incidence of major clinical adverse events compared with balloon PTCA. |
topic |
myocardial infarction stents diabetes mellitus |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2001001200006 |
work_keys_str_mv |
AT luizalbertomattos oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT cindylgrines oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT jeduardodesousa oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT amandagmrsousa oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT greggwstone oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT davidcox oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT eulogiogarcia oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT marieclaudemorice oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT williamoneill oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT loreleigrines oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial AT judithboura oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial |
_version_ |
1725212118267985920 |